A partnership with CELLIANT® means true collaboration.
Nearly all executives believe innovation is critical to the success of their company, likely because innovation is directly tied to profitable growth. Companies who prioritize innovation may see a 16% sales boost, making them 3.5x more likely to outperform competitors.
At the same time, less than 1/3 of large organizations seek out innovation partners to help them grow. We've diagnosed this as the innovation disconnect: a gap between the need for innovation and the ability to successfully deliver upon it.
CELLIANT resolves the innovation disconnect by providing brands with ready-made innovation. As an ingredient brand, we take on the burden of costly and time-consuming research and development, scientific validation and testing, and quality control to deliver a next-level ingredient that you can incorporate into your brand's products, instantly innovating them with our cutting-edge infrared technology. The benefits of working with an ingredient brand are numerous.
To get in touch directly with the Hologenix team member in your local area, please view the appropriate contact details below. For inquiries of a general nature, a form is provided below. You can also contact us via hello@celliant.com.
Lydia Kang
Mr. Sadao Tsuuchi
+81.6.4708.7078
For a full-spectrum experience, find related reading about similar topics below.
CELLIANT is not a good fit for brands that have not already created commercially viable products. But, it is not the case that you must already be selling the product that you plan on adding CELLIANT into – for some partners, we can work together to develop new CELLIANT-powered product lines.
CELLIANT’s regulatory status spans over 50 countries, making CELLIANT an ideal global partner. As part of this regulatory status, CELLIANT is designated as a Class 1 Medical Device in Australia, Canada, the European Union, Japan, New Zealand, the United Arab Emirates and the United Kingdom.
For our purposes, cleared to market means that, based on research in a specific country or region, the evidence supports a conclusion that CELLIANT products and the proposed claims fall outside of the definition of a medical device and no medical device registration is required.
REQUEST INFORMATION
